Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- paranoia
- odd thinking
- restricted range of emotions
- anger and irritability
- excessive emotionality and unstable mood states
- anxiety and tension
- impulsive behaviors
- grandiosity
- evidence of self harm (e.g., scars, burns)
Fatores de risco
- history of abuse
- family history of schizophrenia
- family history of borderline personality disorder (BPD)
- negative parenting interactions
- emotional/disruptive disorder in childhood
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- clinical interview
Investigações a serem consideradas
- suicide risk screening questions
- Standardized Assessment of Personality-Abbreviated Scale (SAPAS)
- Millon Clinical Multiaxial Inventory-III (MCMI-III)
- Structured Clinical Interview for DSM-5-TR Alternative Model for Personality Disorders Version (SCID-5-AMPD)
- Structured Clinical Interview for DSM-5-TR Personality Disorders
- MRI/CT scan of brain
- urine drug screen
- The Primary Care Evaluation of Mental Disorders (PRIME-MD)
- Patient Health Questionnaire-9 (PHQ-9)
- Mood Disorder Questionnaire
- Generalized Anxiety Disorder-7 (GAD-7) and GAD-2
Algoritmo de tratamento
at risk for harming self or others, or unable to attend to basic self-needs
cluster A (odd/eccentric): non-life-threatening, not pregnant or breastfeeding
cluster B (dramatic): non-life-threatening, not pregnant or breastfeeding
cluster C (anxious): non-life-threatening, not pregnant or breastfeeding
multiple features of different personality disorders: non-life-threatening, not pregnant or breastfeeding
any cluster or multiple features of different personality disorders: non-life-threatening, pregnant or breastfeeding
Colaboradores
Autores
Michael J. Schrift, DO, MA

Professor
Department of Psychiatry and Behavioral Sciences
University of Washington
Seattle
WA
Declarações
MJS declares he has no competing interests.
Agradecimentos
Dr Michael J. Schrift would like to gratefully acknowledge Dr Crystal T. Clark, and the late Dr Maria Devens, previous contributors to this topic. He would also like to acknowledge Dr Eric Gausche, who contributed the psychopharmacology sections for the initial version, and Dr Richard Stringham, who reviewed and approved information on the use of imaging and laboratory tests in the diagnosis section in the initial version. MD was an author of references cited in this topic. CTC, EG, and RS declare that they have no competing interests.
Revisores
Anthony W. Bateman, FRCPsych
Consultant Psychiatrist and Visiting Professor
Halliwick Psychotherapy Unit
St Ann’s Hospital
London
UK
Declarações
AWB declares that he has a bias towards the use of mentalization in the treatment of personality disorder.
Robin L. Kissell, MD
Director
Borderline Personality Disorder Initiative
Semel Institute
UCLA
Los Angeles
CA
Declarações
RLK declares that she has no competing interests.
Justin Trevino, MD
Medical Director
Opioid Treatment Program
Dayton Veterans Affairs Medical Center
Dayton
OH
Declarações
JT declares that he has no competing interests.
Dietmar Winkler, MD
Department of Psychiatry and Psychotherapy
Medical University of Vienna
Vienna
Austria
Declarações
DW has received lecture fees from CSC Pharmaceuticals, GlaxoSmithKline, and Pfizer, and has served as a consultant for GlaxoSmithKline.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association; 2022.Texto completo
Keepers GA, Fochtmann LJ, Anzia JM, et al. The American Psychiatric Association practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry. 2024 Nov 1;181(11):1024-8. Resumo
Storebø OJ, Stoffers-Winterling JM, Völlm BA, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020 May 4;5:CD012955.Texto completo Resumo
Cristea IA, Gentili C, Cotet CD, et al. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2017 Apr 1;74(4):319-28.Texto completo Resumo
Abbass AA, Kisely SR, Town JM, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2014 Jul 1;(7):CD004687.Texto completo Resumo
Herpertz SC, Zanarini M, Schulz CS, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of personality disorders. World J Biol Psychiatry. 2007;8(4):212-44.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Mood disorders
- Psychotic disorders
- Anxiety disorders
Mais Diagnósticos diferenciaisDiretrizes
- Treatment of patients with borderline personality disorder
- Antisocial personality disorder: prevention and management
Mais DiretrizesFolhetos informativos para os pacientes
Personality disorders: what are they?
Personality disorders: what are the treatment options?
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal